| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes
|
Campbell, Thomas M.
|
|
|
205 |
2 |
p. 257-266
|
artikel
|
| 2 |
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience
|
Bufman, Hila
|
|
|
205 |
2 |
p. 281-285
|
artikel
|
| 3 |
Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme
|
Kulothungan, Vaitheeswaran
|
|
|
205 |
2 |
p. 323-332
|
artikel
|
| 4 |
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study
|
Doubblestein, David
|
|
|
205 |
2 |
p. 359-370
|
artikel
|
| 5 |
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer
|
Chen, Ying
|
|
|
205 |
2 |
p. 249-256
|
artikel
|
| 6 |
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
|
Sun, Hongxia
|
|
|
205 |
2 |
p. 403-411
|
artikel
|
| 7 |
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study
|
Finsterbusch, Kai
|
|
|
205 |
2 |
p. 413-421
|
artikel
|
| 8 |
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
|
Wimmer, Kerstin
|
|
|
205 |
2 |
p. 227-239
|
artikel
|
| 9 |
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration
|
Wu, Yang
|
|
|
205 |
2 |
p. 371-386
|
artikel
|
| 10 |
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial
|
Ginzac, Angeline
|
|
|
205 |
2 |
p. 267-279
|
artikel
|
| 11 |
Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk
|
Voets, Madelon M.
|
|
|
205 |
2 |
p. 313-322
|
artikel
|
| 12 |
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
|
Coombes, R Charles
|
|
|
205 |
2 |
p. 349-358
|
artikel
|
| 13 |
Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery
|
Faleh, Sohayb
|
|
|
205 |
2 |
p. 303-312
|
artikel
|
| 14 |
Primary MALT lymphoma of the breast: pathological and radiological characteristics
|
Shibahara, Yukiko
|
|
|
205 |
2 |
p. 387-394
|
artikel
|
| 15 |
Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study
|
Hosseini, Yasaman
|
|
|
205 |
2 |
p. 395-402
|
artikel
|
| 16 |
Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns
|
Mokbel, Kefah
|
|
|
205 |
2 |
p. 423-424
|
artikel
|
| 17 |
Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)
|
Gao, Lucy
|
|
|
205 |
2 |
p. 211-226
|
artikel
|
| 18 |
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
|
Plichta, Jennifer K.
|
|
|
205 |
2 |
p. 333-347
|
artikel
|
| 19 |
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
|
Mutai, Raz
|
|
|
205 |
2 |
p. 241-248
|
artikel
|
| 20 |
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry
|
Geurts, Sandra M. E.
|
|
|
205 |
2 |
p. 287-302
|
artikel
|
Tijdschrift beschrijving